Gabriele Schricker

Establishment of a RESEARCH USE ONLY Condensed-Efficient-Fast (CEF) PITX2 workflow for analysis of PITX2 DNA methylation in small tumor tissue samples 

W. Weichert, M. Kiechle, V. Magdolen, 2020 .

Clinical Validation of PITX2 DNA Methylation to Predict Outcome in High-Risk Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy

W. Weichert, J. Lauber, J. Martens, 2018, Breast Care.

Clinical performance of an analytically validated assay in comparison to microarray technology to assess PITX2 DNA-methylation in breast cancer

W. Weichert, J. Lauber, A. Noske, 2018, Scientific Reports.

PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer Patients

A. Walch, W. Weichert, M. Kiechle, 2020, Breast Care.

therascreenPITX2 RGQ PCR assay for the assessment of PITX2 DNA-methylation status to investigate the role of the transcription factor PITX2 and the regulation of the Wnt/ß-catenin pathway in pathophysiological processes.

W. Weichert, M. Kiechle, A. Noske, 2018 .

Clinical performance of an analytically validated assay in comparison to microarray technology to assess PITX2 DNA-methylation in breast cancer

W. Weichert, J. Lauber, J. Martens, 2018, Scientific Reports.